Skip to content

Clinician Communication About Sexual Health

Enhancing Clinician Communication About Sexual Health in Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04262219
Enrollment
32
Registered
2020-02-10
Start date
2020-02-07
Completion date
2020-10-12
Last updated
2022-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The objective of this study is to adapt a previously tested brief intervention aimed at enhancing clinicians communication about sexual health (iSHARE) to a mobile web-based platform showcasing a two-part podcast and to assess the feasibility, acceptability, and preliminary effects of the intervention in breast cancer clinicians.

Detailed description

Specific aims are: 1) To assess the feasibility and acceptability of iSHARE in a mobile learning (mLearning) format and 2) To assess the preliminary effects of iSHARE in a mLearning format.

Interventions

BEHAVIORALiShare

The iShare intervention consists of a two-episode educational podcast series containing information about breast cancer patients' sexual problems, approaches for addressing sexual concerns, and information about discussing sexual concerns with patients, such as initiating a conversation about sexual health and asking questions to assess sexual concern. Both episodes feature expert guests and relevant discussions or case studies.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Fox Chase Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Clinician is a medical oncologist or medical oncology advanced practice clinician (Nurse Practitioner, Physician Assistant) who treats breast cancer patients

Exclusion criteria

* Clinician has participated in previous pilot study of the intervention

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the Intervention Trial - EnrollmentBaselineEnrollment will be measured through measures of participant enrollment defined as the percent of eligible candidates approached who enroll in the pilot trial.
Feasibility of the Intervention Trial - RetentionBaseline up to 1 monthStudy retention will defined as percentage of enrolled participants who complete all study surveys.
Feasibility of the Intervention Trial - Intervention Completion1 monthIntervention completion will defined as percentage of enrolled participants who complete participation in the podcast intervention.
Acceptability1 week up to 1 monthAcceptability will be measured through the percentage of the sample endorsing 6 primary acceptability items favorably at two time points (1 week and 1 month; satisfaction, informativeness, relevance, ease of listening, likelihood to recommend, likelihood to impact practice).
Change in Clinician Knowledge About Sexual Health and Related CommunicationBaseline up to 1 monthClinician knowledge about sexual health and communication will be measured using a 10-item scale asking about common sexual problems experienced by breast cancer patients and the most effective ways to communicate with patients about these issues. Knowledge scores range from 0 to 10, with higher scores indicating more knowledge. Knowledge will be reported as the mean of items answered correctly. Positive mean change scores indicate an increase in knowledge over time.
Change in Clinician Self-Efficacy About Sexual Health CommunicationBaseline up to 1 monthClinician self-efficacy about sexual health communication will be measured using a 3-item scale asking about confidence in discussing sexual concerns with patients. Mean scores range from 0-10, with higher scores indicating higher self-efficacy. Positive mean change scores indicate an increase in self-efficacy over time.
Change in Clinician Outcome Expectancies for Sexual Health CommunicationBaseline up to 1 monthClinician outcome expectancies for sexual health communication will be measured using a 7-item scale asking about expected positive results in discussing sexual concerns with patients. Mean scores range from 0-10, with higher scores indicating better expected outcomes. Positive mean change scores indicate an increase in outcome expectancies over time.
Change in Clinician Comfort With Communicating About Sexual HealthBaseline up to 1 monthClinician comfort with sexual health communication will be measured using a 7-item scale asking about comfort level in discussing sexual concerns with patients. Mean scores range from 0-10, with higher scores indicating a higher level of comfort. Positive mean change scores indicate an increase in comfort level over time.
Change in Clinician Communication About Sexual HealthBaseline up to 1 monthClinician communication about sexual health will be measured using a 3-item scale asking about recent communication practices around sexual health (initiating conversations, offering information, giving referrals). Mean scores range from 1-5, with higher scores indicating higher amounts of communication. Positive mean change scores indicate an increase in communication behaviors over time.

Countries

United States

Participant flow

Participants by arm

ArmCount
iShare
Participants will be asked to listen to a podcast intervention. iShare: The iShare intervention consists of a two-episode educational podcast series containing information about breast cancer patients' sexual problems, approaches for addressing sexual concerns, and information about discussing sexual concerns with patients, such as initiating a conversation about sexual health and asking questions to assess sexual concern. Both episodes feature expert guests and relevant discussions or case studies.
32
Total32

Baseline characteristics

CharacteristiciShare
Age, Continuous42.28 years
STANDARD_DEVIATION 9.69
Clinical role
Nurse Practitioner
7 Participants
Clinical role
Oncologist
22 Participants
Clinical role
Physician Assistant
3 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
23 Participants
Region of Enrollment
United States
32 participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
9 Participants
Years of Practice in Oncology
0-5 Years
11 Participants
Years of Practice in Oncology
11-15 Years
6 Participants
Years of Practice in Oncology
6-10 Years
7 Participants
Years of Practice in Oncology
More than 15 Years
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 32
other
Total, other adverse events
0 / 32
serious
Total, serious adverse events
0 / 32

Outcome results

Primary

Acceptability

Acceptability will be measured through the percentage of the sample endorsing 6 primary acceptability items favorably at two time points (1 week and 1 month; satisfaction, informativeness, relevance, ease of listening, likelihood to recommend, likelihood to impact practice).

Time frame: 1 week up to 1 month

ArmMeasureValue (NUMBER)
iShareAcceptability80 percentage of participants
Primary

Change in Clinician Comfort With Communicating About Sexual Health

Clinician comfort with sexual health communication will be measured using a 7-item scale asking about comfort level in discussing sexual concerns with patients. Mean scores range from 0-10, with higher scores indicating a higher level of comfort. Positive mean change scores indicate an increase in comfort level over time.

Time frame: Baseline up to 1 month

ArmMeasureValue (MEAN)
iShareChange in Clinician Comfort With Communicating About Sexual Health0.80 units on a scale
Primary

Change in Clinician Communication About Sexual Health

Clinician communication about sexual health will be measured using a 3-item scale asking about recent communication practices around sexual health (initiating conversations, offering information, giving referrals). Mean scores range from 1-5, with higher scores indicating higher amounts of communication. Positive mean change scores indicate an increase in communication behaviors over time.

Time frame: Baseline up to 1 month

ArmMeasureValue (MEAN)
iShareChange in Clinician Communication About Sexual Health0.16 units on a scale
Primary

Change in Clinician Knowledge About Sexual Health and Related Communication

Clinician knowledge about sexual health and communication will be measured using a 10-item scale asking about common sexual problems experienced by breast cancer patients and the most effective ways to communicate with patients about these issues. Knowledge scores range from 0 to 10, with higher scores indicating more knowledge. Knowledge will be reported as the mean of items answered correctly. Positive mean change scores indicate an increase in knowledge over time.

Time frame: Baseline up to 1 month

ArmMeasureValue (MEAN)
iShareChange in Clinician Knowledge About Sexual Health and Related Communication1.6 score on a scale
Primary

Change in Clinician Outcome Expectancies for Sexual Health Communication

Clinician outcome expectancies for sexual health communication will be measured using a 7-item scale asking about expected positive results in discussing sexual concerns with patients. Mean scores range from 0-10, with higher scores indicating better expected outcomes. Positive mean change scores indicate an increase in outcome expectancies over time.

Time frame: Baseline up to 1 month

ArmMeasureValue (MEAN)
iShareChange in Clinician Outcome Expectancies for Sexual Health Communication0.52 units on a scale
Primary

Change in Clinician Self-Efficacy About Sexual Health Communication

Clinician self-efficacy about sexual health communication will be measured using a 3-item scale asking about confidence in discussing sexual concerns with patients. Mean scores range from 0-10, with higher scores indicating higher self-efficacy. Positive mean change scores indicate an increase in self-efficacy over time.

Time frame: Baseline up to 1 month

ArmMeasureValue (MEAN)
iShareChange in Clinician Self-Efficacy About Sexual Health Communication0.76 units on a scale
Primary

Feasibility of the Intervention Trial - Enrollment

Enrollment will be measured through measures of participant enrollment defined as the percent of eligible candidates approached who enroll in the pilot trial.

Time frame: Baseline

Population: 33 participants were analyzed because 33 eligible study candidates were approached for enrollment. Of these, 32 participants enrolled.

ArmMeasureValue (NUMBER)
iShareFeasibility of the Intervention Trial - Enrollment96.97 percent of eligible study candidates
Primary

Feasibility of the Intervention Trial - Intervention Completion

Intervention completion will defined as percentage of enrolled participants who complete participation in the podcast intervention.

Time frame: 1 month

ArmMeasureValue (NUMBER)
iShareFeasibility of the Intervention Trial - Intervention Completion93.75 percentage of participants
Primary

Feasibility of the Intervention Trial - Retention

Study retention will defined as percentage of enrolled participants who complete all study surveys.

Time frame: Baseline up to 1 month

ArmMeasureValue (NUMBER)
iShareFeasibility of the Intervention Trial - Retention93.75 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026